BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27807141)

  • 21. Inhibition of telomerase recruitment and cancer cell death.
    Nakashima M; Nandakumar J; Sullivan KD; Espinosa JM; Cech TR
    J Biol Chem; 2013 Nov; 288(46):33171-80. PubMed ID: 24097987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and functional analysis of the human POT1-TPP1 telomeric complex.
    Rice C; Shastrula PK; Kossenkov AV; Hills R; Baird DM; Showe LC; Doukov T; Janicki S; Skordalakes E
    Nat Commun; 2017 Apr; 8():14928. PubMed ID: 28393830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The POT1-TPP1 telomere complex is a telomerase processivity factor.
    Wang F; Podell ER; Zaug AJ; Yang Y; Baciu P; Cech TR; Lei M
    Nature; 2007 Feb; 445(7127):506-10. PubMed ID: 17237768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TPP1 mutagenesis screens unravel shelterin interfaces and functions in hematopoiesis.
    Grill S; Padmanaban S; Friedman A; Perkey E; Allen F; Tesmer VM; Chase J; Khoriaty R; Keegan CE; Maillard I; Nandakumar J
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33822766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7.
    Zemp I; Lingner J
    J Biol Chem; 2014 Oct; 289(41):28595-606. PubMed ID: 25172512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of human telomerase recruitment by TPP1-POT1.
    Sekne Z; Ghanim GE; van Roon AM; Nguyen THD
    Science; 2022 Mar; 375(6585):1173-1176. PubMed ID: 35201900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex interaction network revealed by mutation of human telomerase 'insertion in fingers' and essential N-terminal domains and the telomere protein TPP1.
    Lambert-Lanteigne P; Young A; Autexier C
    J Biol Chem; 2023 Mar; 299(3):102916. PubMed ID: 36649908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structurally conserved TELR region on shelterin protein TPP1 is essential for telomerase processivity but not recruitment.
    Sandhu R; Sharma M; Wei D; Xu L
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34282008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation- and Dyskeratosis Congenita Cluster-Dependent Fashion.
    Nelson ND; Dodson LM; Escudero L; Sukumar AT; Williams CL; Mihalek I; Baldan A; Baird DM; Bertuch AA
    Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human telomere POT1-TPP1 complex and its role in telomerase activity regulation.
    Wang F; Lei M
    Methods Mol Biol; 2011; 735():173-87. PubMed ID: 21461822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyskeratosis congenita.
    Bessler M; Wilson DB; Mason PJ
    FEBS Lett; 2010 Sep; 584(17):3831-8. PubMed ID: 20493861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
    Choo S; Lorbeer FK; Regalado SG; Short SB; Wu S; Rieser G; Bertuch AA; Hockemeyer D
    Blood; 2022 Aug; 140(6):608-618. PubMed ID: 35421215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple facets of TPP1 in telomere maintenance.
    Rajavel M; Mullins MR; Taylor DJ
    Biochim Biophys Acta; 2014 Sep; 1844(9):1550-9. PubMed ID: 24780581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita-like phenotypes.
    Tummala H; Collopy LC; Walne AJ; Ellison A; Cardoso S; Aksu T; Yarali N; Aslan D; Fikret Akata R; Teo J; Songyang Z; Pontikos N; Fitzgibbon J; Tomita K; Vulliamy T; Dokal I
    Blood; 2018 Sep; 132(12):1349-1353. PubMed ID: 30064976
    [No Abstract]   [Full Text] [Related]  

  • 36. TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.
    Zhu J; Liu W; Chen C; Zhang H; Yue D; Li C; Zhang L; Gao L; Huo Y; Liu C; Giaccone G; Zhang B; Wang C
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1509-1519. PubMed ID: 31016380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
    Gramatges MM; Bertuch AA
    Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo.
    Abreu E; Aritonovska E; Reichenbach P; Cristofari G; Culp B; Terns RM; Lingner J; Terns MP
    Mol Cell Biol; 2010 Jun; 30(12):2971-82. PubMed ID: 20404094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for sister telomere cohesion in telomere elongation by telomerase.
    Houghtaling BR; Canudas S; Smith S
    Cell Cycle; 2012 Jan; 11(1):19-25. PubMed ID: 22157096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.